Stephen Clarke
Stephen Clarke
Professor of Medicine, University of Sydney and Medical Oncologist, RNSH and Genesis Care
Verified email at
Cited by
Cited by
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study
LB Saltz, S Clarke, E Díaz-Rubio, W Scheithauer, A Figer, R Wong, ...
Journal of clinical oncology 26 (12), 2013-2019, 2008
Cancer-related inflammation and treatment effectiveness
CI Diakos, KA Charles, DC McMillan, SJ Clarke
The Lancet Oncology 15 (11), e493-e503, 2014
The systemic inflammation-based neutrophil–lymphocyte ratio: experience in patients with cancer
GJK Guthrie, KA Charles, CSD Roxburgh, PG Horgan, DC McMillan, ...
Critical reviews in oncology/hematology 88 (1), 218-230, 2013
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer
J Cassidy, S Clarke, E Díaz-Rubio, W Scheithauer, A Figer, R Wong, ...
Journal of clinical oncology 26 (12), 2006-2012, 2008
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
A de Gramont, E Van Cutsem, HJ Schmoll, J Tabernero, S Clarke, ...
The lancet oncology 13 (12), 1225-1233, 2012
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
N Van Zandwijk, N Pavlakis, SC Kao, A Linton, MJ Boyer, S Clarke, ...
The Lancet Oncology 18 (10), 1386-1396, 2017
Clinical pharmacokinetics of docetaxel
SJ Clarke, LP Rivory
Clinical pharmacokinetics 36, 99-114, 1999
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
W Chua, KA Charles, VE Baracos, SJ Clarke
British journal of cancer 104 (8), 1288-1295, 2011
A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
MJ Proctor, DC McMillan, DS Morrison, CD Fletcher, PG Horgan, ...
British journal of cancer 107 (4), 695-699, 2012
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
BT Li, R Shen, D Buonocore, ZT Olah, A Ni, MS Ginsberg, GA Ulaner, ...
Journal of Clinical Oncology 36 (24), 2532-2537, 2018
Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer
ET Morgan, KB Goralski, M Piquette-Miller, KW Renton, GR Robertson, ...
Drug Metabolism and Disposition 36 (2), 205-216, 2008
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE …
HS Wasan, P Gibbs, NK Sharma, J Taieb, V Heinemann, J Ricke, ...
The Lancet Oncology 18 (9), 1159-1171, 2017
High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy
SCH Kao, N Pavlakis, R Harvie, JL Vardy, MJ Boyer, N van Zandwijk, ...
Clinical cancer research 16 (23), 5805-5813, 2010
Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review
EL Davis, B Oh, PN Butow, BA Mullan, S Clarke
The oncologist 17 (11), 1475-1481, 2012
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results
J Cassidy, S Clarke, E Díaz-Rubio, W Scheithauer, A Figer, R Wong, ...
British journal of cancer 105 (1), 58-64, 2011
Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis
QP Janssen, S Buettner, M Suker, BR Beumer, P Addeo, P Bachellier, ...
JNCI: Journal of the National Cancer Institute 111 (8), 782-794, 2019
Impact of medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial
B Oh, P Butow, B Mullan, S Clarke, P Beale, N Pavlakis, E Kothe, L Lam, ...
Annals of Oncology 21 (3), 608-614, 2010
Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy
KA Slaviero, SJ Clarke, LP Rivory
The lancet oncology 4 (4), 224-232, 2003
The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer
JCY Chan, DL Chan, CI Diakos, A Engel, N Pavlakis, A Gill, SJ Clarke
Annals of surgery 265 (3), 539-546, 2017
Diagnosis of gastrointestinal bleeding: A practical guide for clinicians
BSM Kim, BT Li, A Engel, JS Samra, S Clarke, ID Norton, AE Li
World journal of gastrointestinal pathophysiology 5 (4), 467, 2014
The system can't perform the operation now. Try again later.
Articles 1–20